Standard Diagnostics, Inc., often referred to as Standardia, is a leading player in the in vitro diagnostics industry, headquartered in South Korea (KR). Founded in 2000, the company has established a strong presence in major operational regions across Asia, Europe, and North America. Specialising in the development and manufacturing of diagnostic kits, Standard Diagnostics offers a diverse range of products, including rapid tests and immunoassays, which are distinguished by their accuracy and reliability. The company has achieved significant milestones, including numerous certifications and partnerships that underscore its commitment to quality and innovation. With a robust market position, Standard Diagnostics is recognised for its contributions to healthcare, particularly in the fields of infectious diseases and chronic conditions. Its dedication to research and development continues to drive advancements in diagnostic solutions, making it a trusted name in the industry.
We don't have data for Standard Diagnostics, Inc., but we can show you information about their parent organization instead.
View parent company